RemifentanilNeonatal respiratory depression following in-utero exposure: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2024卷 / 1期

关键词：

D O I：

10.1007/s40278-024-66380-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：398 / 398

相关论文

共 50 条

[1] IodineFetal goitre following in-utero exposure: 3 case reports
Reactions Weekly, 2021, 1885 (1) : 276 - 276
[2] AlbendazoleCongenital anomalies following in-utero exposure: 3 case reports
Reactions Weekly, 2017, 1682 (1) : 23 - 23
[3] PrilocaineTransient methaemoglobinaemia following an in-utero exposure: 3 case reports
Reactions Weekly, 2018, 1693 (1) : 428 - 428
[4] AntineoplasticsTeratogenicity following in-utero exposure: 4 case reports
Reactions Weekly, 2017, 1672 (1) : 39 - 39
[5] WarfarinEmbryopathy following in-utero exposure: 2 case reports
Reactions Weekly, 2019, 1752 (1) : 387 - 387
[6] MethotrexateCraniosynostosis following an in-utero exposure: 4 case reports
Reactions Weekly, 2017, 1633 (1) : 479 - 479
[7] IndometacinDuctus arteriosus constriction, oligohydramnios and respiratory distress syndrome following in-utero exposure: 3 case reports
Reactions Weekly, 2021, 1848 (1) : 215 - 215
[8] DiazepamNeurological depression and difficulty to maintain respiratory drive following in-utero exposure: case report
Reactions Weekly, 2016, 1593 (1) : 75 - 75
[9] Budesonide/formoterolUnilateral orofacial cleft following in-utero exposure: 3 case reports
Reactions Weekly, 2021, 1864 (1) : 88 - 88
[10] MethotrexateMobius syndrome following in-utero exposure: 2 case reports
Reactions Weekly, 2022, 1896 (1) : 286 - 286

← 1 2 3 4 5 →